Dr. David G. Mata focuses his practice on the preparation and prosecution of patent applications. He counsels clients from various fields, including biologics, chemistry, biotechnology, pharmaceuticals, and medical devices, on patent life cycle management, freedom-to-operate, and patent validity/invalidity analyses. David also has experience securing, defending, and challenging patents through patent prosecution and contested proceedings before the U.S. Patent and Trademark Office.
Prior to joining the firm, David was an Oak Ridge Institution for Science and Education (ORISE) Postdoctoral Fellow at the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD). In this role, he was a member of the agent mitigation group, which is focused on screening candidate protein bioscavengers as therapeutics against chemical warfare nerve agents. During his postdoctoral research, David was mainly responsible for the expression of Paraoxonase 1 (PON1) variants in animal models through the use of an adeno/adeno-associated virus delivery system in order to assess the protective efficacy of the candidate bioscavenger.
Concentrations
• U.S. and international patent strategy and lifecycle management
• Life Sciences
• Patent prosecution and opinions
• IP due diligence
Experience
Previous Experience
• Oak Ridge Institution for Science and Education (ORISE) Fellow, U.S. Army Medical Research Institute of Chemical Defense (USAMRICD), 2012-2015
• MALDI Consultant, Quanta BioDesign, 2010-2012
